1. Natural killer cell cytotoxicity is a predictor of outcome for patients with high risk myelodysplastic syndrome and oligoblastic acute myeloid leukemia treated with azacytidine. Issue 10 (24th August 2019) Authors: Tsirogianni, Maria; Grigoriou, Eirini; Kapsimalli, Violetta; Dagla, Kleopatra; Stamouli, Maria; Gkirkas, Konstantinos; Konsta, Eve; Karagiannidou, Angeliki; Gkodopoulos, Konstantinos; Stavroulaki, Georgia; Pappa, Vassiliki; Angelopoulou, Maria; Lowdell, Mark; Tsirigotis, Panagiotis Journal: Leukemia & lymphoma Issue: Volume 60:Issue 10(2019) Page Start: 2457 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗